Page last updated: 2024-10-28

ifosfamide and Dermatomyositis

ifosfamide has been researched along with Dermatomyositis in 2 studies

Dermatomyositis: A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshinaga, A1
Hayashi, T1
Ishii, N1
Ohno, R1
Watanabe, T1
Yamada, T1
Tsang, KW1
Lam, WK1
Ip, M1

Other Studies

2 other studies available for ifosfamide and Dermatomyositis

ArticleYear
Successful cure of dermatomyositis after treatment of nonseminomatous testicular cancer.
    International journal of urology : official journal of the Japanese Urological Association, 2005, Volume: 12, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Embryonal; Cisplatin; Dermatomyosi

2005
Response of dermatomyositis co-existing with non-small cell lung cancer to chemotherapy.
    Respiratory medicine, 1998, Volume: 92, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dermatomy

1998